These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 24362548)

  • 21. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies.
    Salarinia R; Sahebkar A; Peyvandi M; Mirzaei HR; Jaafari MR; Riahi MM; Ebrahimnejad H; Nahand JS; Hadjati J; Asrami MO; Fadaei S; Salehi R; Mirzaei H
    Curr Cancer Drug Targets; 2016; 16(9):773-788. PubMed ID: 26638884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view.
    Hodjat M; Rahmani S; Khan F; Niaz K; Navaei-Nigjeh M; Mohammadi Nejad S; Abdollahi M
    Arch Toxicol; 2017 Jul; 91(7):2577-2597. PubMed ID: 28516248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.
    López-Pedrera C; Pérez-Sánchez C; Ramos-Casals M; Santos-Gonzalez M; Rodriguez-Ariza A; Cuadrado MJ
    Clin Dev Immunol; 2012; 2012():974648. PubMed ID: 21941583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analytical and therapeutic profiles of DNA methylation alterations in cancer; an overview of changes in chromatin arrangement and alterations in histone surfaces.
    Norollahi SE; Vahidi S; Shams S; Keymoradzdeh A; Soleymanpour A; Solymanmanesh N; Mirzajani E; Jamkhaneh VB; Samadani AA
    Horm Mol Biol Clin Investig; 2023 Sep; 44(3):337-356. PubMed ID: 36799246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic control of gene expression: Potential implications for cancer treatment.
    Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
    Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel microRNA promoter microarray for ChIP-on-chip assay to identify epigenetically regulated microRNAs.
    Saito Y; Suzuki H; Taya T; Nishizawa M; Tsugawa H; Matsuzaki J; Hirata K; Saito H; Hibi T
    Biochem Biophys Res Commun; 2012 Sep; 426(1):33-7. PubMed ID: 22906743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutual regulation of microRNAs and DNA methylation in human cancers.
    Wang S; Wu W; Claret FX
    Epigenetics; 2017 Mar; 12(3):187-197. PubMed ID: 28059592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs and Epigenetics.
    Moutinho C; Esteller M
    Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
    Rondelet G; Wouters J
    Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic control of autoimmune diseases: from bench to bedside.
    Picascia A; Grimaldi V; Pignalosa O; De Pascale MR; Schiano C; Napoli C
    Clin Immunol; 2015 Mar; 157(1):1-15. PubMed ID: 25576661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional and epigenetic regulation of follicular T-helper cells and their role in autoimmunity.
    Qiu H; Wu H; Chan V; Lau CS; Lu Q
    Autoimmunity; 2017 Mar; 50(2):71-81. PubMed ID: 28263097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coordinated Actions of MicroRNAs with other Epigenetic Factors Regulate Skeletal Muscle Development and Adaptation.
    Bianchi M; Renzini A; Adamo S; Moresi V
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin as a regulator of epigenetic events.
    Teiten MH; Dicato M; Diederich M
    Mol Nutr Food Res; 2013 Sep; 57(9):1619-29. PubMed ID: 23754571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases.
    Wang Z; Lu Q; Wang Z
    Cell Physiol Biochem; 2017; 41(2):645-660. PubMed ID: 28214857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.